Benchmark raised the firm’s price target on Imax (IMAX) to $30 from $27 and keeps a Buy rating on the shares. The firm’s confidence in the company’s growth prospects “continues to strengthen,” supported by a “robust” film slate, a growing installation network, and significant operating leverage, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- B. Riley names 5 media, entertainment stocks positioned for re-ratings
- Dolphin Entertainment price target lowered to $5 from $8 at Maxim
- Auxly Cannabis Group Achieves Record-Breaking Q3 2024
- And the Oscar for Best Financial Results Goes to…IMAX (IMAX)
- Imax price target raised to $28 from $24 at Barrington